Angiolab, Inc. (XKON:251280)
South Korea · Delayed Price · Currency is KRW 1,850.00
-315.00 (-14.55%)
At close: Nov 12, 2026
Angiolab Market Cap
Angiolab has a market cap or net worth of 6.46 billion as of November 13, 2026. It is the 44,888th most valuable company in the world and the 2,696th biggest in South Korea. Its market cap has decreased by 55.90% in one year.
Market Cap
6.46B
Enterprise Value
n/a
Revenue
702.62M
Global Rank
Country Rank
#2,696 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, Angiolab's market cap has decreased from 8.46B to 6.46B, a decrease of -23.65%. That is a compound annual growth rate of -2.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 6.46B | -24.80% |
| Dec 30, 2025 | 8.59B | -62.64% |
| Dec 30, 2024 | 22.99B | 34.78% |
| Dec 28, 2023 | 17.06B | -12.06% |
| Dec 29, 2022 | 19.40B | -6.10% |
| Dec 30, 2021 | 20.66B | -31.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Progen | 27.43B |
| Epibiotech | 25.88B |
| ADBiotech | 20.62B |
| Poongjeon Pharmacy CO.,LTD. | 20.51B |
| Shaperon | 19.61B |
| Plumbline Life Sciences | 18.69B |
| Moogene Medi | 18.60B |
| NGeneBio | 14.96B |